Australian Politics Forum - Ivermectin research at the Monash institute

Belgarion

Gold Member

Offline

Australian Politics

Posts: 5473
Gender: male

Re: Ivermectin research at the Monash institute
Reply #15 - Sep 12^th, 2021 at 10:44am

Ajax wrote on Sep 12^th, 2021 at 10:02am:

John Dillermand wrote on Sep 12^th, 2021 at 9:52am:

Ajax wrote on Sep 12^th, 2021 at 9:51am:

Yes against measles and such with vaccines that have been developed to immunise you from a particular disease.

The vaccines are not vaccines otherwise I would line up and have it.

They are flu shots.

And forcing grown adults to take flu shots in not what a democratically elected government does.

Or have i missed something.

Yes, flu shots are also vaccines.

Yeah sure these days whatever big pharma says is law right.

A flu shot is a treatment not a vaccine.

Vaccines prevent you from getting the sickness and spreading it to others, or so it was in the old days.

Flu shots may help you fight the bug but you can still catch it and spread it.

That is not a vaccine......!!!

Sheeple are so easily deceived......... Kiss

One of the most breathtakingly stupid posts I have ever seen, and given the standard of some of the posters here that takes some doing. Shocked

Back to top

"I may not agree with what you say, but I will defend to the death your right to say it."

Voltaire.....(possibly)

IP Logged

Sprintcyclist

Gold Member

Offline

OzPolitic

Posts: 40772
Gender: male

Re: Ivermectin research at the Monash institute
Reply #16 - Sep 12^th, 2021 at 5:12pm

John Dillermand wrote on Sep 12^th, 2021 at 10:31am:

Borody... yep trusted.

And whats the date on that press release?

Quote:

........... 15 Aug 2020 .......

‘There are a number of studies that are amazingly successful – we’re talking close to 100%,’ Professor Borody told Sky News.

He said this treatment has not been used in Australian patients, but that it has been used successfully in China and Bangladesh.

‘So I am behind the ivermectin, doxycycline, zinc treatment because it has very few side effects, and is a real killer of coronavirus,’ Professor Borody said. .................

https://www1.racgp.org.au/newsgp/clinical/insufficient-evidence-to-currently-sup...

Given the situation we are in and the UN resolution that no govt should withold a medicine from people this should be 'trialled'.

ie - if a sick person signs a waiver they should be given invermectin and the results kept to go towards this 'study'.

We can't 'wait' for reliable data to emerge.

Back to top

Modern Classic Right Wing

IP Logged

aquascoot

Gold Member

Offline

Australian Politics

Posts: 35179
Gender: male

Re: Ivermectin research at the Monash institute
Reply #17 - Sep 12^th, 2021 at 5:59pm

sprint,

i hope youre taking zinc.

completely safe and definitely helpful .

now no one is pormoting it as they are obsessed with vaccines.

but this is an article from the USA national institute of health.

if you arent taking it, you are batsh**t crazy

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255455/

Abstract
In view of the emerging COVID-19 pandemic caused by SARS-CoV-2 virus, the search for potential protective and therapeutic antiviral strategies is of particular and urgent interest. Zinc is known to modulate antiviral and antibacterial immunity and regulate inflammatory response. Despite the lack of clinical data, certain indications suggest that modulation of zinc status may be beneficial in COVID-19. In vitro experiments demonstrate that Zn2+ possesses antiviral activity through inhibition of SARS-CoV RNA polymerase. This effect may underlie therapeutic efficiency of chloroquine known to act as zinc ionophore. Indirect evidence also indicates that Zn2+ may decrease the activity of angiotensin-converting enzyme 2 (ACE2), known to be the receptor for SARS-CoV-2. Improved antiviral immunity by zinc may also occur through up-regulation of interferon α production and increasing its antiviral activity. Zinc possesses anti-inflammatory activity by inhibiting NF-κB signaling and modulation of regulatory T-cell functions that may limit the cytokine storm in COVID-19. Improved Zn status may also reduce the risk of bacterial co-infection by improving mucociliary clearance and barrier function of the respiratory epithelium, as well as direct antibacterial effects against S. pneumoniae. Zinc status is also tightly associated with risk factors for severe COVID-19 including ageing, immune deficiency, obesity, diabetes, and atherosclerosis, since these are known risk groups for zinc deficiency. Therefore, Zn may possess protective effect as preventive and adjuvant therapy of COVID-19 through reducing inflammation, improvement of mucociliary clearance, prevention of ventilator-induced lung injury, modulation of antiviral and antibacterial immunity.

Back to top

IP Logged

Sprintcyclist

Gold Member

Offline

OzPolitic

Posts: 40772
Gender: male

Re: Ivermectin research at the Monash institute
Reply #18 - Sep 12^th, 2021 at 7:11pm

aquascoot wrote on Sep 12^th, 2021 at 5:59pm:

sprint,

i hope youre taking zinc.

completely safe and definitely helpful .

now no one is pormoting it as they are obsessed with vaccines.

but this is an article from the USA national institute of health.

if you arent taking it, you are batsh**t crazy

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255455/

Abstract
In view of the emerging COVID-19 pandemic caused by SARS-CoV-2 virus, the search for potential protective and therapeutic antiviral strategies is of particular and urgent interest. Zinc is known to modulate antiviral and antibacterial immunity and regulate inflammatory response. Despite the lack of clinical data, certain indications suggest that modulation of zinc status may be beneficial in COVID-19. In vitro experiments demonstrate that Zn2+ possesses antiviral activity through inhibition of SARS-CoV RNA polymerase. This effect may underlie therapeutic efficiency of chloroquine known to act as zinc ionophore. Indirect evidence also indicates that Zn2+ may decrease the activity of angiotensin-converting enzyme 2 (ACE2), known to be the receptor for SARS-CoV-2. Improved antiviral immunity by zinc may also occur through up-regulation of interferon α production and increasing its antiviral activity. Zinc possesses anti-inflammatory activity by inhibiting NF-κB signaling and modulation of regulatory T-cell functions that may limit the cytokine storm in COVID-19. Improved Zn status may also reduce the risk of bacterial co-infection by improving mucociliary clearance and barrier function of the respiratory epithelium, as well as direct antibacterial effects against S. pneumoniae. Zinc status is also tightly associated with risk factors for severe COVID-19 including ageing, immune deficiency, obesity, diabetes, and atherosclerosis, since these are known risk groups for zinc deficiency. Therefore, Zn may possess protective effect as preventive and adjuvant therapy of COVID-19 through reducing inflammation, improvement of mucociliary clearance, prevention of ventilator-induced lung injury, modulation of antiviral and antibacterial immunity.

Thanks, I have quite often and have some in the cupboard.
Prob don't need it as my diet is good however ......... Will get some right now.

Back to top

Modern Classic Right Wing

IP Logged

wombatwoody

Gold Member

Offline

Australian Politics

Posts: 3240
Wombat NSW

Re: Ivermectin research at the Monash institute
Reply #19 - Sep 12^th, 2021 at 9:14pm

Just published in the peer-reviewed American Journal of Therapeutics, Dr. Tess Lawrie, an expert in medicinal evidence, along with other experts in population health and gastroenterology out of the United Kingdom (UK), conducted a comprehensive meta-analysis involving the certainty of evidence using an approach known as GRADE, which led to the focus on twenty-four ivermectin-centered randomized controlled trials involving 3,406 participants.

The authors concluded based on this extensive review that ivermectin actually reduced the risk of death compared with no ivermectin ...

Dr. Lawrie shared with the TrialSite:

“We are overjoyed to have the product of months of hard work finally published! And what a wonderful author team – it’s been an honour to work with people of such high integrity, who maintained a spirit of hope and optimism in spite of all the difficulties with which we have been confronted. Thank you for not giving up! Now the authorities have all the evidence they need to approve ivermectin immediately.”

TrialSite’s been one of the few, if not the only, media platforms to consistently chronicle ivermectin-based research since the initial findings of a group of scientists last April at Monash University that the generic drug absolutely destroys the SARS-CoV-2 pathogen in a lab setting. TrialSite chronicled the organization, conduct, and conclusion of dozens of studies since then. The platform’s only been rivaled by the anonymously owned platform that tracks every ivermectin study, now at 60. One of the key authors here, Dr. Tess Lawrie, has been a guest on the TrialSite podcast and is a frequent contributor.

Lead Research/Investigator

Andrew Bryant, MSc, Division of Gastroenterology, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom

Theresa A. Lawrie, MBBCh, PhD, Division of Gastroenterology, Evidence-based Medicine Consultancy, Bath, United Kingdom

Therese Dowswell, PhD, Division of Gastroenterology, Evidence-based Medicine Consultancy, Bath, United Kingdom

Edmund J. Fordham, PhD, Division of Gastroenterology, Evidence-based Medicine Consultancy, Bath, United Kingdom

Scott Mitchell, MBChB, MRCS, Emergency Department, Princess Elizabeth Hospital, Guernsey, United Kingdom

Sarah R. Hill, PhD, Division of Gastroenterology, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom

Tony C. Tham, MD, FRCP, Division of Gastroenterology, Ulster Hospital, Dundonald, Belfast, Northern Ireland, United Kingdom

https://www.palmerfoundation.com.au/uk-based-meta-analysis-peer-reviewed-publish...

Back to top

We are benefiting from ... the attack on the Twin Towers and Pentagon, and the American struggle in Iraq.

Benjamin Netanyahu, quoted in Ma’ariv, 16 April 2008

IP Logged